Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,334 across all filing types
Latest filing 2020-07-24 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
BREZTRI AEROSPHERE APPROVED IN THE US FOR THE MAINTENANCE TREATMENT OF COPD
Foreign Filer Report
2020-07-24 English
Breztri Aerosphere approved in the US for COPD
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 9972T' and is dated July 24, 2020. It announces a specific corporate event: the US FDA approval of Breztri Aerosphere for COPD maintenance treatment, including details on clinical trials and financial milestones. The presence of the RNS Number and the nature of the announcement (a material event disclosure) strongly indicate this is a regulatory news service release. Since it is a general regulatory announcement that doesn't fit neatly into specific categories like ER, DIV, or CAP, the most appropriate classification is the general regulatory filing category.
2020-07-24 English
HOLDING(S) IN COMPANY
Foreign Filer Report
2020-07-22 English
HOLDING(S) IN COMPANY
Foreign Filer Report
2020-07-22 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document text clearly indicates it is a 'TR-1: Standard form for notification of major holdings' submitted to the FCA (Financial Conduct Authority) regarding AstraZeneca PLC. This form is used to report changes in significant share ownership (crossing thresholds). The key elements are the form title (TR-1), the issuer (AstraZeneca PLC), the date of the event (20/07/2020), and the resulting percentage holdings (e.g., 4.96%). This directly corresponds to the definition of Major Shareholding Notification.
2020-07-22 English
HOLDING(S) IN COMPANY
Foreign Filer Report
2020-07-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.